Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2006-08-02
2009-10-20
Coleman, Brenda L (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S260100, C514S234200, C514S252160, C514S227800, C544S061000, C544S117000, C544S255000, C540S524000
Reexamination Certificate
active
07605154
ABSTRACT:
The present invention is directed to novel thiazolopyrimidine compounds of Formula (I) or a form or composition thereofand the use thereof as inhibitors of ATP-protein kinase interactions.
REFERENCES:
patent: 2004/0053908 (2004-03-01), Funahashi et al.
patent: 2007/0244133 (2007-10-01), Bower et al.
CAS printout, pp. 1-9, downloaded Apr. 24, 2008.
Goldenberg-Furmanov, et al., Cancer Research, Feb. 1, 2004, 64, 1058-1064.
Shah, et al., Science, Jul. 16, 2004, vol. 305, 399-401.
Donato, et al., Blood, Jan. 15, 2003, 101(2), 690-698.
Wobig, D., Liebigs Ann. Chem., 1989, 409-412 (See English Abstract).
McKee RL and Bost RW,J. Am. Chem. Soc., 1946, 68, 2506-7.
International Search Report re: PCT/US06/30149 dated Aug. 24, 2007.
Binnun Eva
Connolly Peter J.
Johnson Sigmond G.
Lin Ronghui
Middleton Steven A.
Coleman Brenda L
Janssen Pharmaceutica N.V.
Moore Susanna
LandOfFree
Substituted Thiazolo [4,5-d]pyrimidines as protein kinase... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted Thiazolo [4,5-d]pyrimidines as protein kinase..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted Thiazolo [4,5-d]pyrimidines as protein kinase... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4086711